

Boehringer Ingelheim has a large and experienced global team managing and conducting clinical trials in many indications. During the past decade from 2001 to 2010, Boehringer Ingelheim conducted or sponsored 1,320 studies with 106 substances in 87 countries from all regions of the world.
Boehringer Ingelheim conducts and sponsors clinical trials to establish safety and efficacy of the drugs we develop, either for use in their initial indication or in additional indications.